Dosidal · Switzerland

Rifampicine Labatec, gélules

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:50264 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 50264
atc: J04AB02
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 1989-08-11
term: zugelassen
valid_until: 9999-12-31
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: J04AB02
authorisation_number: 50264
form: KAHA
holder: Labatec Pharma SA
holder_partner_nr: 1000310
it_number: 08.02.1.
name: Rifampicine Labatec, gélules
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
ovhigJig-cnLopeRlF4YF2V81h7xDy3kqH5LiVXGxKzpfnMwCiXv3i8m94zmiruMUaMV_Ofio2ucHn2okTKdJw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:50264 · Related records in other markets · Dosidal